Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
104 studies found for:    "spinocerebellar degenerations" OR "marinesco-sjogren syndrome"
Show Display Options
Rank Status Study
21 Completed Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Type 3
Condition: Spinocerebellar Ataxia Type 3
Interventions: Drug: varenicline;   Drug: placebo
22 Completed Biomarkers in Autosomal Dominant Cerebellar Ataxia
Conditions: Spinocerebellar Ataxia Type 1;   Spinocerebellar Ataxia Type 2;   Spinocerebellar Ataxia, Autosomal Recessive 3;   Episodic Ataxia, Type 7
Intervention: Other: metabolic and imaging biomarkers in SCA1,2,3 and 7 patients
23 Completed Neuromuscular Electrical Stimulation on Median Nerve Facilitates Low Motor Cortex Excitability in Human With Spinocerebellar Ataxia
Condition: Spinocerebellar Ataxia
Intervention: Device: Neuromuscular electrical stimulation
24 Withdrawn Pilot Study of Safety and Efficacy of Sodium Phenylbutyrate in Spinocerebellar Ataxia Type 3
Condition: Spinocerebellar Ataxia Type 3
Interventions: Drug: Placebo;   Drug: Sodium Phenylbutyrate
25 Recruiting Functional and Structural Imaging and Motor Control in Spinocerebellar Ataxia
Condition: Spinocerebellar Ataxia
Interventions: Behavioral: Error-reduction;   Behavioral: International Cooperative Ataxia Rating Scale;   Behavioral: Scale for the Assessment and Rating of Ataxia;   Behavioral: Beck Depression Inventory, 2nd Ed;   Behavioral: Stroop;   Behavioral: Purdue Pegboard;   Behavioral: Brief Test of Attention;   Behavioral: 6-minute Walk;   Behavioral: Hand Grip Dynamometer;   Behavioral: Montreal Cognitive Assessment;   Behavioral: Physical Performance Function;   Behavioral: Biomechanical Assessments of Dysmetria;   Behavioral: Neurophysiological assessment of brain activity;   Behavioral: Biomechanical gait analysis
26 Completed High-Dose Intravenous Immunoglobulin to Treat Cerebellar Degeneration
Condition: Spinocerebellar Degenerations
Intervention: Drug: high-dose intravenous immunoglobulin (IVIG)
27 Unknown  RISCA : Prospective Study of Individuals at Risk for SCA1, SCA2, SCA3, SCA6, SCA7
Condition: Spinocerebellar Ataxias
28 Completed Coordination Training With Complete Body Video Games in Children and Adults With Degenerative Ataxias
Condition: Spinocerebellar Ataxia
Intervention: Other: General training
29 Recruiting Slowing Down Disease Progression in Premanifest SCA: a Piloting Interventional Exergame Trial
Condition: Spinocerebellar Ataxia
Intervention: Other: Motor training
30 Completed The Effect of Whole Body Vibration Training on Neuromuscular Property in Individuals With Ataxia
Condition: Spinocerebellar Ataxia
Intervention: Other: Whole body vibration training
31 Completed The Investigation of the Pre-movement Facilitation of Agonist-antagonist Muscles and the Effect of the Feedforward Rehabilitation in Individuals With Hypermetria
Condition: Spinocerebellar Atrophy (SCA)
Intervention: Other: Temporal electrical stimulation
32 Recruiting Efficacy and Safety Study of Mesenchymal Stem Cells (Stemchymal®) in Polyglutamine Spinocerebellar Ataxia
Condition: Cerebellar Ataxia
Interventions: Biological: Stemchymal®;   Procedure: Excipients
33 Completed A Phase II Double Blind Comparative Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
Condition: SCD
Interventions: Drug: KPS-0373;   Drug: Placebo
34 Recruiting The EUROSCA Natural History Study
Condition: Spinocerebellar Ataxia
35 Unknown  Machado-Joseph Disease in Israel
Condition: Spinocerebellar Ataxia 3
36 Completed Clinical and Molecular Correlations in Spinocerebellar Ataxia Type 10 (SCA10)
Condition: Hereditary Ataxia
37 Completed Preliminary Study of the Scale To Assess Ataxia and Neurologic Dysfunction (STAND)
Conditions: Spinocerebellar Ataxia - All Sub-types;   Friedreich's Ataxia
Intervention: Other: Ataxia rating scale
38 Active, not recruiting Study To Assess Safety, Tolerability and Efficacy of Intravenous Cabaletta in Patients With Machado-Joseph Disease
Condition: Machado-Joseph Disease / Spinocerebellar Ataxia 3
Intervention: Drug: Cabaletta for IV infusion once weekly during 24 weeks
39 Unknown  The Influence of Deep TMS on Cerebellar Signs in Patients With Machado Joseph Disease
Condition: Machado Joseph Disease (SCA3)
Intervention: Device: Deep TMS
40 Completed Efficacy of Riluzole in Hereditary Cerebellar Ataxia
Condition: Cerebellar Ataxia
Interventions: Drug: riluzole;   Drug: Placebo comparator

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years